Sands Capital Ventures as of June 30, 2022
Portfolio Holdings for Sands Capital Ventures
Sands Capital Ventures holds 19 positions in its portfolio as reported in the June 2022 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Uipath Com Cl A (PATH) | 19.0 | $69M | 3.8M | 18.19 | |
| Dice Therapeutics | 13.4 | $49M | 3.1M | 15.52 | |
| Doordash Com Cl A (DASH) | 10.6 | $39M | 602k | 64.17 | |
| Nu Holdings Com Cl A (NU) | 9.4 | $34M | 9.1M | 3.74 | |
| Samsara Com Cl B | 8.3 | $30M | 2.7M | 11.17 | |
| Snowflake Com Cl A (SNOW) | 8.2 | $30M | 215k | 139.06 | |
| Karuna Therapeutics Ord | 6.0 | $22M | 173k | 126.51 | |
| 10X Genomics Com Cl A (TXG) | 6.0 | $22M | 482k | 45.25 | |
| Cincor Pharma | 4.9 | $18M | 950k | 18.84 | |
| Acumen Pharmaceuticals (ABOS) | 4.4 | $16M | 3.4M | 4.70 | |
| Olink Hldg Ab (OLK) | 2.9 | $11M | 706k | 15.20 | |
| 908 Devices (MASS) | 1.8 | $6.7M | 326k | 20.59 | |
| Tarsus Pharmaceuticals (TARS) | 1.0 | $3.8M | 260k | 14.60 | |
| Repligen Corporation (RGEN) | 1.0 | $3.7M | 23k | 162.39 | |
| Samsara Com Cl A (IOT) | 1.0 | $3.6M | 326k | 11.17 | |
| Taysha Gene Therapies (TSHA) | 0.7 | $2.7M | 725k | 3.72 | |
| Candel Therapeutics (CADL) | 0.7 | $2.6M | 812k | 3.24 | |
| Spruce Biosciences (SPRB) | 0.4 | $1.4M | 787k | 1.74 | |
| Absci Corp (ABSI) | 0.1 | $192k | 58k | 3.32 |
